p53 Gene Family: Structural, Functional and Evolutionary Features
Journal:
Current Genomics
Volume:
4
Page:
13-26
Author(s):
D'Erchia A. M., Tullo A., Pesole G., Saccone C. and Sbisa E.
Dual Topoisomerase I / II Inhibitors in Cancer Therapy
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
339-353
Author(s):
William A. Denny and Bruce C. Baguley
Cytochrome P450-based Gene Therapy for Cancer Treatment: From Concept to the Clinic
Journal:
Current Drug Metabolism
Volume:
3
Page:
609-622
Author(s):
Youssef Jounaidi
Gap Junctions as Targets for Cancer Chemoprevention and Chemotherapy
Journal:
Current Drug Targets
Volume:
3
Page:
465-482
Author(s):
J.E. Trosko and R.J. Ruch
Cytokines and their Antagonists as Therapeutic Agents
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
2201-2207
Author(s):
Liljana Stevceva
Gene Therapy and Biologic Therapy with Interleukin?4
Journal:
Current Gene Therapy
Volume:
2
Page:
437-450
Author(s):
Hideho Okada and Naruo Kuwashima
Endostatin: Preclinical Development as an Anticancer Agent
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
233-243
Author(s):
T. Bachelot, R. Pawliuk and E. Jouanneau
Recent Advances in the Diagnosis and Therapy of Primary Adrenal Insufficiency
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
2
Page:
251-272
Author(s):
Stefano Laureti, Fausto Santeusanio and Alberto Falorni
Therapeutic Enhancement of IL-2 Through Molecular Design
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2171-2183
Author(s):
Delanie J. Cassell, Shurjeel Choudhri, Rachel Humphrey, Robert E. Martell, Theresa Reynolds and Armen B. Shanafelt
Agents Targeting Ras Signaling Pathway
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
2259-2267
Author(s):
J. E. Dancey